United Services Automobile Association bought a new position in shares of Humana Inc. (NYSE:HUM - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 2,856 shares of the insurance provider's stock, valued at approximately $756,000.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Cary Street Partners Investment Advisory LLC lifted its position in Humana by 63.9% during the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock worth $31,000 after acquiring an additional 46 shares during the last quarter. Riverview Trust Co bought a new stake in shares of Humana in the first quarter valued at about $34,000. Garde Capital Inc. acquired a new stake in Humana in the 1st quarter worth about $36,000. Zions Bancorporation National Association UT acquired a new position in Humana in the 1st quarter valued at $37,000. Finally, Whipplewood Advisors LLC lifted its position in shares of Humana by 639.1% during the 1st quarter. Whipplewood Advisors LLC now owns 170 shares of the insurance provider's stock valued at $45,000 after acquiring an additional 147 shares during the period. Institutional investors and hedge funds own 92.38% of the company's stock.
Wall Street Analyst Weigh In
HUM has been the subject of a number of analyst reports. Morgan Stanley dropped their price target on Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a research note on Thursday, July 31st. Piper Sandler cut their price target on shares of Humana from $288.00 to $272.00 and set a "neutral" rating for the company in a report on Thursday, July 31st. Wells Fargo & Company reduced their price target on shares of Humana from $348.00 to $344.00 and set an "overweight" rating on the stock in a research report on Thursday, August 14th. Bank of America boosted their price objective on shares of Humana from $285.00 to $312.00 and gave the company a "neutral" rating in a research report on Tuesday, September 2nd. Finally, Barclays raised their target price on Humana from $275.00 to $315.00 and gave the company an "equal weight" rating in a report on Friday, September 5th. Seven equities research analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $289.24.
Read Our Latest Research Report on HUM
Humana Trading Down 0.8%
Shares of NYSE:HUM traded down $2.36 during midday trading on Friday, hitting $276.36. 1,138,341 shares of the stock were exchanged, compared to its average volume of 1,648,760. The business's 50-day moving average price is $265.34 and its 200 day moving average price is $257.18. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $325.75. The stock has a market capitalization of $33.24 billion, a price-to-earnings ratio of 21.21, a P/E/G ratio of 1.64 and a beta of 0.44.
Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). The business had revenue of $32.39 billion during the quarter, compared to analyst estimates of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The company's revenue was up 9.6% compared to the same quarter last year. During the same quarter last year, the company posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. Analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.
Humana Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Friday, September 26th. Humana's payout ratio is 27.17%.
About Humana
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Recommended Stories

Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.